Free Trial
→ Forget NVDA. Put $1,000 into this stock now (From Chaikin Analytics) (Ad)tc pixel Free BAX Stock Alerts

Baxter International (BAX) Stock Forecast & Price Target

Baxter International logo
$23.03 -0.66 (-2.79%)
Closing price 09/19/2025 03:59 PM Eastern
Extended Trading
$23.20 +0.17 (+0.76%)
As of 09/19/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Baxter International - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold
Based on 10 Analyst Ratings
Sell
1
Hold
6
Buy
3

Based on 10 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Hold." Out of the 10 analysts, 1 has given a sell rating, 6 have given a hold rating, and 3 have given a buy rating for BAX.

Consensus Price Target

$30.11
30.75% Upside
According to the 10 analysts' twelve-month price targets for Baxter International, the average price target is $30.11. The highest price target for BAX is $42.00, while the lowest price target for BAX is $24.00. The average price target represents a forecasted upside of 30.75% from the current price of $23.03.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAX Analyst Ratings Over Time

TypeCurrent Forecast
9/20/24 to 9/20/25		1 Month Ago
8/21/24 to 8/21/25		3 Months Ago
6/22/24 to 6/22/25		1 Year Ago
9/21/23 to 9/20/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
2 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$30.11$30.11$37.25$41.73
Forecasted Upside30.75% Upside26.28% Upside24.06% Upside8.41% Upside
Consensus RatingHoldHoldHoldHold

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Baxter International Stock vs. The Competition

TypeBaxter InternationalMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.78
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside30.75% Upside14,929.43% Upside11.30% Upside
News Sentiment Rating
Positive News

See Recent BAX News
Positive News
Positive News
Export to Excel
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
8/4/2025Barclays
3 of 5 stars
Matt Miksic
Matt Miksic
Not Rated
Lower TargetOverweight$41.00 ➝ $36.00+60.64%
8/4/2025UBS Group
4 of 5 stars
Danielle Antalffy
Danielle Antalffy
Not Rated
Lower TargetNeutral$35.00 ➝ $24.00+8.46%
8/4/2025Stifel Nicolaus
4 of 5 stars
Rick Wise
Rick Wise
Not Rated
Reiterated RatingBuy ➝ Hold$36.00 ➝ $25.00+13.79%
8/1/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Larry Biegelsen
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetEqual Weight$33.00 ➝ $24.00+11.28%
8/1/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 DowngradeBuy ➝ Neutral$25.00+14.89%
7/15/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Patrick Wood
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetUnderweight$28.00 ➝ $27.00-5.36%
7/9/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Joanne Wuensch
Joanne Wuensch
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetNeutral$34.00 ➝ $32.00+7.35%
7/8/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Vijay Kumar
Vijay Kumar
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetOutperform$44.00 ➝ $42.00+41.41%
2/24/2025Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
J. Hellweg
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeHold ➝ Buy
2/21/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Robbie Marcus
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetNeutral$38.00 ➝ $36.00+7.50%
5/10/2024TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 DowngradeBuy ➝ Hold$40.00+11.27%
3/5/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Boost TargetNeutral$42.00 ➝ $45.00+2.93%
10/24/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Boost TargetHold$35.00 ➝ $50.00+52.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:24 PM ET.


Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, September 19, 2025. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Baxter International Inc.:

  • The current stock price is around $23.93, which may present a buying opportunity for investors looking for value in the healthcare sector.
  • Baxter International Inc. has shown a revenue increase of 4.3% compared to the same quarter last year, indicating growth potential in its operations.
  • The company has a positive return on equity of 16.96%, suggesting effective management and profitability relative to shareholder equity.
  • Analysts have a consensus rating of "Hold" with an average target price of $30.11, indicating potential upside for investors if the stock approaches this target.
  • Baxter International Inc. recently declared a quarterly dividend of $0.17 per share, providing a steady income stream for investors, despite a negative dividend payout ratio.

Baxter International
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Baxter International Inc. for these reasons:

  • The stock has experienced a significant decrease in target prices from various analysts, with UBS Group and Wells Fargo both lowering their targets to $24.00, reflecting a cautious outlook.
  • Baxter International Inc. reported earnings per share of $0.59, missing consensus estimates, which may raise concerns about its ability to meet future expectations.
  • The company has a negative net margin of 1.42%, indicating that it is currently operating at a loss relative to its revenue, which could be a red flag for potential investors.
  • With a price-to-earnings ratio of -79.52, the stock may be viewed as overvalued, as this metric suggests that the company is not generating profits relative to its stock price.
  • The debt-to-equity ratio of 1.30 indicates that the company has a relatively high level of debt compared to its equity, which could pose risks in times of financial instability.

BAX Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $30.11, with a high forecast of $42.00 and a low forecast of $24.00.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There is currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.

According to analysts, Baxter International's stock has a predicted upside of 30.75% based on their 12-month stock forecasts.

Over the previous 90 days, Baxter International's stock had 1 downgrade by analysts.

Baxter International has been rated by research analysts at Barclays, Citigroup, Evercore ISI, Morgan Stanley, Stifel Nicolaus, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Baxter International less than other "medical" companies. The consensus rating for Baxter International is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BAX compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NYSE:BAX) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
Crypto Gets Official Government Backing—Here's the Winner
Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...
Crypto 101 Media | Sponsoredtc pixel
An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...
Porter & Company | Sponsoredtc pixel
Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...
Brownstone Research | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...
Stansberry Research | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...
Weiss Ratings | Sponsoredtc pixel